Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, et al. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the anemia in chronic heart failure: outcomes and resource utilization (ANCHOR) study. Circulation 2006;113:2713–23.CrossrefPubMedGoogle Scholar
Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, et al. Anemia and mortality in heart failure patients: a systematic review and meta-analysis. J Am Coll Cardiol 2008;52:818–27.CrossrefWeb of SciencePubMedGoogle Scholar
van der Meer P, Lok DJ, Januzzi JL, Lipsic E, van Wijngaarden J, Voors AA, et al. Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients. Europ Heart J 2008;29:1510–5.CrossrefGoogle Scholar
Moe GW, Ezekowitz JA, O’Meara E, Lepage S, Howlett JG, Fremes S, et al. The 2014 Canadian cardiovascular society heart failure management guidelines focus update: anemia, biomarkers, and recent therapeutic trial implications. Can J Cardiol 2015;31:3–16.Web of ScienceCrossrefGoogle Scholar
Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12,065 patients with new-onset heart failure. Circulation 2003;107:223–5.PubMedCrossrefGoogle Scholar
Maggioni AP, Anand I, Gottlieb SO, Latini R, Tognoni G, Cohn JN. Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors. J Am Coll Cardiol 2002;40:1414–21.CrossrefPubMedGoogle Scholar
Kallergis EM, Mavrakis HE, Vardas PE. Anaemia and heart failure: is its correction a therapeutic target? The role of erythropoietin. Hell J Cardiol 2005;46:222–5.Google Scholar
Palazzuoli A, Silverberg D, Iovine F, Capobianco S, Giannotti G, Calabrò A. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia. Am Heart J 2006;152:1096–115.PubMedGoogle Scholar
George J, Patal S, Wexler D, Abashidze A, Shmilovich H, Barak T, et al. Circulating erythropoietin levels and prognosis in patients with congestive heart failure. Comparison with neurohormonal and inflammatory markers. Arch Intern Med 2005;165:1304–09.PubMedCrossrefGoogle Scholar
Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 2000;35:1737–44.CrossrefGoogle Scholar
Pham I, Andrivet P, Sediame S, Defouilloy C, Moutereau S, Wirquin V, et al. Increased erythropoietin synthesis in patients with COLD or left heart failure is related to alterations in renal haemodynamics. Eur J Clin Invest 2001;31:103–9.PubMedCrossrefGoogle Scholar
Zahidova KK. The role of the level of serum erythropoietin on the patients with anemic heart failure. Eur J Heart Fail (Supplements) 2013;12(S1):71.Google Scholar
Silverberg DS, Wexler D, Sheps D, Blum M, Keren G, Baruch R, et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol 2001;37:1775–80.CrossrefGoogle Scholar
van Veldhuisen DJ, McMurray JJ. Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial. Eur J Heart Fail 2007;9:110–2.PubMedCrossrefWeb of ScienceGoogle Scholar
About the article
Published Online: 2017-12-07
Published in Print: 2018-01-26
Author contributions: The author has accepted responsibility for the entire content of this submitted manuscript and approved the submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of the data; in the writing of the report; or in the decision to submit the report for publication.